Cargando…

Neutralizing Antibodies against Lassa Virus Lineage I

Lassa virus (LASV) is the causative agent of the deadly Lassa fever (LF). Seven distinct LASV lineages circulate through western Africa, among which lineage I (LI), the first to be identified, is particularly resistant to antibody neutralization. Lineage I LASV evades neutralization by half of known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buck, Tierra K., Enriquez, Adrian S., Schendel, Sharon L., Zandonatti, Michelle A., Harkins, Stephanie S., Li, Haoyang, Moon-Walker, Alex, Robinson, James E., Branco, Luis M., Garry, Robert F., Saphire, Erica Ollmann, Hastie, Kathryn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426445/ https://www.ncbi.nlm.nih.gov/pubmed/35730904 http://dx.doi.org/10.1128/mbio.01278-22

Ejemplares similares

Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies
por: Enriquez, Adrian S., et al.
Publicado: (2022)

Structural Basis for the dsRNA Specificity of the Lassa Virus NP Exonuclease
por: Hastie, Kathryn M., et al.
Publicado: (2012)

Lassa virus glycoprotein: stopping a moving target
por: Hastie, Kathryn M, et al.
Publicado: (2018)

Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence
por: Hastie, Kathryn M., et al.
Publicado: (2023)

Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV
por: Hastie, Kathryn M., et al.
Publicado: (2016)

Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
por: Heinrich, Megan L., et al.
Publicado: (2020)

Novel attempts launched toward universal Sarbecovirus vaccine
por: Li, Haoyang, et al.
Publicado: (2021)

Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
por: Robinson, James E., et al.
Publicado: (2016)

Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses
por: Hastie, Kathryn M, et al.
Publicado: (2012)

Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses
por: Amanat, Fatima, et al.
Publicado: (2018)

Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
por: Callaway, Heather M., et al.
Publicado: (2022)

SARS-CoV-2 antibodies specific to the mesa and inner side of spike protein receptor binding domain maintain high affinities for both D614G and b.1.351 variants
por: Li, Kan, et al.
Publicado: (2022)

Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever
por: Boisen, Matthew L., et al.
Publicado: (2018)

Lassa Fever in Post-Conflict Sierra Leone
por: Shaffer, Jeffrey G., et al.
Publicado: (2014)

A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection
por: Ronk, Adam J., et al.
Publicado: (2023)

High crossreactivity of human T cell responses between Lassa virus lineages
por: Sullivan, Brian M., et al.
Publicado: (2020)

New Lineage of Lassa Virus, Togo, 2016
por: Whitmer, Shannon L.M., et al.
Publicado: (2018)

Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals
por: Fang, Jingru, et al.
Publicado: (2022)

Detection of Lassa Virus, Mali
por: Safronetz, David, et al.
Publicado: (2010)

Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms
por: Branco, Luis M, et al.
Publicado: (2009)

Development and Structural Analysis of Antibody Therapeutics for Filoviruses
por: Yu, Xiaoying, et al.
Publicado: (2022)

CD164 is a host factor for lymphocytic choriomeningitis virus entry
por: Bakkers, Mark J. G., et al.
Publicado: (2022)

Lassa fever — the road ahead
por: Garry, Robert F.
Publicado: (2022)

Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development
por: Ibukun, Francis Ifedayo
Publicado: (2020)

Elevated l-threonine is a biomarker for Lassa fever and Ebola
por: Gale, Trevor V., et al.
Publicado: (2020)

Lifted Up from Lockdown
por: Arturo, Emilia C., et al.
Publicado: (2020)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)

Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization
por: Norris, Michael J., et al.
Publicado: (2022)

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever
por: Branco, Luis M, et al.
Publicado: (2010)

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus
por: Cross, Robert W., et al.
Publicado: (2023)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
por: Perrett, Hailee R., et al.
Publicado: (2023)

Pathogenesis of Lassa Fever
por: Yun, Nadezhda E., et al.
Publicado: (2012)

Plasmodium infection disrupts the T follicular helper cell response to heterologous immunization
por: Fontana, Mary F, et al.
Publicado: (2023)

Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope
por: West, Brandyn R., et al.
Publicado: (2018)

Data set on Lassa fever in post-conflict Sierra Leone
por: Shaffer, Jeffrey G., et al.
Publicado: (2019)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Structural Basis for Differential Neutralization of Ebolaviruses
por: Bale, Shridhar, et al.
Publicado: (2012)

Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
por: Bornholdt, Zachary A., et al.
Publicado: (2016)

Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage
por: Manning, John T., et al.
Publicado: (2015)

Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys
por: Mateo, Mathieu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jrppcemgp0t0ltfk16l84qpqb5